These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 1682045)
1. N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1. Gattegno L; Sadeghi H; Saffar L; Bladier D; Clerget-Raslain B; Gluckman JC; Bahraoui E Carbohydr Res; 1991 Jun; 213():79-93. PubMed ID: 1682045 [TBL] [Abstract][Full Text] [Related]
2. Mannosyl/N-acetyl-beta-D-glucosaminyl binding properties of the envelope glycoprotein of human immunodeficiency virus type 2. Haïdar M; Gluckman JC; Gattegno L Glycobiology; 1992 Oct; 2(5):429-35. PubMed ID: 1281021 [TBL] [Abstract][Full Text] [Related]
3. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1. Haidar M; Seddiki N; Gluckman JC; Gattegno L Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814 [TBL] [Abstract][Full Text] [Related]
4. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1). Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938 [TBL] [Abstract][Full Text] [Related]
5. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans. Rabehi L; Ferriere F; Saffar L; Gattegno L Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416 [TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus. Seddiki N; Ramdani A; Saffar L; Portoukalian J; Gluckman JC; Gattegno L Biochim Biophys Acta; 1994 Feb; 1225(3):289-96. PubMed ID: 8312376 [TBL] [Abstract][Full Text] [Related]
7. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network. Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820 [TBL] [Abstract][Full Text] [Related]
8. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4. Andersen O; Sørensen AM; Svehag SE; Fenouillet E Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409 [TBL] [Abstract][Full Text] [Related]
9. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E; Miquelis R; Drillien R Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025 [TBL] [Abstract][Full Text] [Related]
10. Sugar-binding sites with specificity to N-acetyl-D-glucosaminides in middle ear mucosa of the guinea pig. Tanimura F; Morioka H Eur Arch Otorhinolaryngol; 1993; 250(6):337-41. PubMed ID: 7505088 [TBL] [Abstract][Full Text] [Related]
11. Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine. Shilatifard A; Merkle RK; Helland DE; Welles JL; Haseltine WA; Cummings RD J Virol; 1993 Feb; 67(2):943-52. PubMed ID: 8419650 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration. D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9. Chen YH; Ebenbichler C; Vornhagen R; Schulz TF; Steindl F; Böck G; Katinger H; Dierich MP AIDS; 1992 Jun; 6(6):533-9. PubMed ID: 1388873 [TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells. Wells DE; Compans RW Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. Chirmule N; Goonewardena H; Pahwa S; Pasieka R; Kalyanaraman VS; Pahwa S J Biol Chem; 1995 Aug; 270(33):19364-9. PubMed ID: 7642615 [TBL] [Abstract][Full Text] [Related]
16. Membrane glycolipids and human immunodeficiency virus infection of primary macrophages. Seddiki N; Ben Younes-Chennoufi A; Benjouad A; Saffar L; Baumann N; Gluckman JC; Gattegno L AIDS Res Hum Retroviruses; 1996 May; 12(8):695-703. PubMed ID: 8744580 [TBL] [Abstract][Full Text] [Related]
17. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. Fenouillet E; Gluckman JC J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778 [TBL] [Abstract][Full Text] [Related]
18. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells. Rodriguez D; Rodriguez JR; Esteban M AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199 [TBL] [Abstract][Full Text] [Related]
19. Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation. Hemming A; Bolmstedt A; Flodby P; Lundberg L; Gidlund M; Wigzell H; Olofsson S Arch Virol; 1989; 109(3-4):269-76. PubMed ID: 2558637 [TBL] [Abstract][Full Text] [Related]
20. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans. Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]